SHAREHOLDER ALERT: PRA FSCT CEMI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong


SHAREHOLDER ALERT: PRA FSCT CEMI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Tuesday, June 23, 2020 5:35 PM

NEW YORK, NY / ACCESSWIRE / June 23, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

ProAssurance Corporation (NYSE:PRA)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/proassurance-corporation-loss-submission-form?prid=7506&wire=1
Lead Plaintiff Deadline: August 17, 2020
Class Period: April 26, 2019 - May 7, 2020

Allegations against PRA include that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.

Forescout Technologies, Inc. (NASDAQ:FSCT)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/forescout-technologies-inc-loss-submission-form-2?prid=7506&wire=1
Lead Plaintiff Deadline: August 10, 2020
Class Period: February 6, 2020 - May 15, 2020

Allegations against FSCT include that: (1) Forescout was experiencing a significant and disproportionate decline in its financial performance; (2) the foregoing was reasonably likely to have a material negative impact on Forescout's planned acquisition by Advent International Corp.; and (3) as a result of the foregoing, defendants' statements about its business and operations were materially false and misleading at all relevant times.

Chembio Diagnostics, Inc. (NASDAQ:CEMI)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/chembio-diagnostics-inc-loss-submission-form?prid=7506&wire=1
Lead Plaintiff Deadline: August 17, 2020
Class Period: March 12, 2020 - June 16, 2020

According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong


SHARE ARTICLE